Seno Medical is leading commercialization efforts in opto-acoustic imaging of breast cancer. Seno’s opto-acoustic technology ... combines both laser optics and conventional ultrasound technology to provide fused functional and anatomical imaging in real time. The result is a tool that delivers additional functional information regarding suspicious breast masses and potentially increases confidence in making a breast biopsy decision. For more information or to answer any questions call 210-615-6501 or email digitalmarketing@senomedical.com. Seno’s Imagio™ breast imaging system received the CE Mark (April 2014) and has completed a post-market surveillance and clinical follow-up study in Europe. The device is for Investigational Use Only in the United States until Pre-Market Approval is finalized from the FDA. read more